ITRI Q2 Earnings Beat, Sales Lag, Stock Sinks 10% on Mixed Outlook

Itron (ITRI) reported strong Q2 2025 non-GAAP EPS of $1.62, significantly beating estimates, and achieved record gross margins and operating income. However, the stock declined 10% as the company issued a mixed full-year outlook, raising its 2025 EPS guidance midpoint by 13% to $6.00-$6.20 while simultaneously cutting its revenue forecast midpoint by nearly 3% to $2.35-$2.4 billion, citing a challenging near-term regulatory and customer landscape despite a record $4.5 billion backlog. The market's negative reaction highlights concerns over revenue deceleration despite improved profitability and robust demand indicators.

Analysis

Itron Inc. (ITRI) presented a dichotomous second-quarter 2025 report, characterized by exceptional profitability clashing with decelerating revenue growth and a cautious near-term outlook, which prompted a 10% decline in its share price. The company delivered a significant bottom-line beat, with non-GAAP EPS of $1.62 exceeding consensus estimates by 21.8% and its own guidance. This performance was driven by strong operational execution, evidenced by a 230 basis point year-over-year expansion in gross margin to 36.9% and record non-GAAP operating income of $82 million. However, revenue was nearly flat at $607 million, missing consensus, with product sales declining 3% due to project delays and a challenging regulatory environment. The market's negative reaction was primarily fueled by the company's revised full-year 2025 guidance, which lowered the revenue midpoint by nearly 3% while simultaneously raising the EPS midpoint by 13%. This suggests a strategic pivot towards higher-margin business, but also signals near-term top-line headwinds, a concern reinforced by a weak Q3 outlook that projects a 6% year-over-year revenue decline and an 18% EPS drop at the midpoint. Despite these challenges, underlying demand appears robust, as indicated by a record backlog of $4.5 billion and strong cash flow generation, creating a clear conflict between near-term execution risk and long-term potential.

Key Decisions for Investors

• Investors should weigh the significant near-term risk from lowered revenue guidance and a weak Q3 forecast against the company's demonstrated ability to expand margins and improve profitability.
• The 10% share price decline may offer an attractive entry point for those with a long-term thesis, but caution is warranted as the market is clearly prioritizing top-line growth and near-term execution over current profitability.
• Monitor the conversion rate of the record $4.5 billion backlog into recognized revenue, as any acceleration in project deployment could serve as a major positive catalyst and invalidate current market concerns.
• Pay close attention to the growth rate of the high-margin 'Outcomes' segment, which grew 9%, as its performance is a key indicator of the success of Itron's strategic shift toward more profitable software and recurring revenue streams.